Israeli defense exports rose 30% in 2024, hitting a record despite war. Elbit Systems (ESLT) is the key public read-through. The next earnings will test if valuation already reflects the growth.
Alpha Score of 57 reflects moderate overall profile with moderate momentum, moderate value, moderate quality, moderate sentiment.
Israel’s defense exports rose 30% in 2024, setting a new record even as the military diverts resources to sustain its own operations. The growth contradicts a simple read that war would crowd out export capacity. A sharper market take sees three mechanics at work: foreign buyers seeking combat-tested systems made by Israeli firms, the country’s defense-industrial base expanding production lines faster than analysts expected, and a shift in product mix toward higher-margin guided weapons and cyber tools.
The export record comes 15 months after the October 7, 2023 attack and the conflicts that followed. Naively, one might assume that meeting the domestic military’s urgent needs would lower surplus output for foreign customers. The data suggests the opposite. Israeli defense companies invested heavily in parallel production capacity, partly through government co‑investment, and prioritized short‑cycle orders that clear backlogs quickly.
For a trader watching the sector, the immediate implication is that demand is both durable and price‑inelastic. Countries that have used Israeli equipment in combat recently – or that see their own threat profiles rising – are ordering now rather than later. That dynamic reduces the risk of a sudden order cliff after the current conflict settles.
The largest publicly traded Israeli defense contractor is Elbit Systems (ESLT). The company reports order backlog and margin data quarterly, and the export jump aligns directly with its recent guidance of “continued growth across all divisions.”
A key difference between a cyclical defense play and a structural one is order visibility. ESLT’s backlog was already at a record before the 2024 export numbers. The 30% national export increase implies that Elbit likely holds a meaningful share of that growth, given its exposure to land systems, C4ISR, and munitions. If Elbit’s Q4 2024 or Q1 2025 results show backlog expanding faster than sales, that would confirm that revenue growth is real and not just price inflation on existing contracts.
The risk lies in valuation. The defense sector has repriced sharply since 2022. ESLT’s earnings multiple sits near historically high levels. If export growth decelerates – because production capacity is fully utilized or because foreign buyers pause after a stockpiling wave – the stock could re-rate downward even if absolute revenue continues rising. The 30% export figure alone does not guarantee that ESLT will beat consensus next quarter.
Confirmation signals include Elbit’s organic order growth exceeding 15%, improvement in gross margins as the product mix shifts to software‑heavy systems, and continued geographic diversification away from Israel‑linked political risk.
Weakness signals would be any commentary from Elbit or peers about supply chain bottlenecks forcing export delays, or a shift in Israeli government policy that requires domestic priority over foreign contracts. Another flag is a slowdown in global defense budgets after the current geopolitical cycle peaks.
For now, the 30% export jump forces the market to update its baseline for Israeli defense firms. The question is whether that baseline is already priced into stocks that have run hard in 2024. The next quarterly filing from Elbit Systems will provide the first concrete test.
For broader sector context, see AlphaScala’s stock market analysis and a guide to best stock brokers for trading international defense names.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.